X-152255817-A-G
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong
The ENST00000370314.9(GABRA3):āc.512T>Cā(p.Leu171Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000898 in 111,383 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000370314.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRA3 | NM_000808.4 | c.512T>C | p.Leu171Pro | missense_variant | 5/10 | ENST00000370314.9 | NP_000799.1 | |
GABRA3 | XM_006724811.4 | c.512T>C | p.Leu171Pro | missense_variant | 5/9 | XP_006724874.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRA3 | ENST00000370314.9 | c.512T>C | p.Leu171Pro | missense_variant | 5/10 | 1 | NM_000808.4 | ENSP00000359337 | P1 | |
GABRA3 | ENST00000535043.1 | c.512T>C | p.Leu171Pro | missense_variant | 5/10 | 1 | ENSP00000443527 | P1 | ||
GABRA3 | ENST00000417858.1 | n.182T>C | non_coding_transcript_exon_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000898 AC: 1AN: 111383Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33593
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.00000898 AC: 1AN: 111383Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33593
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 15, 2023 | Variant summary: GABRA3 c.512T>C (p.Leu171Pro) results in a non-conservative amino acid change located in the Neurotransmitter-gated ion-channel ligand binding domain (IPR006202) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 182956 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.512T>C in individuals affected with Epilepsy, X-Linked 2, With Or Without Impaired Intellectual Development And Dysmorphic Features and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at